Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of infections in association with severe lymphopenia

被引:0
|
作者
Cook, S. [1 ]
Leist, T. [2 ]
Comi, G. [3 ,4 ]
Montalban, X. [5 ]
Sylvester, E. [6 ]
Hicking, C. [6 ]
Dangond, F. [7 ]
机构
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Neuroimmunol, Philadelphia, PA 19107 USA
[3] Univ Vita Salute San Raffaele, Osped San Raffaele, Dept Neurol, Milan, Italy
[4] Univ Vita Salute San Raffaele, Osped San Raffaele, Inst Expt Neurol, Milan, Italy
[5] Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Barcelona, Spain
[6] Merck KGaA, Darmstadt, Germany
[7] EMD Serono Inc, Billerica, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P635
引用
收藏
页码:299 / 300
页数:2
相关论文
共 50 条
  • [41] INTEGRATED SAFETY ANALYSIS; CLADRIBINE IN MULTIPLE SCLEROSIS (MS)
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Sylvester, Elke
    Hicking, Christine
    Dangond, Fernando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A49 - A49
  • [42] An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis
    Galazka, A.
    Nolting, A.
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Hicking, C.
    Dangond, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 133 - 133
  • [43] Rates of lymphopenia year-by-year in patients with relapsing multiple sclerosis treated and retreated with cladribine tablets 3.5mg/kg
    Cook, S.
    Comi, G.
    Giovannoni, G.
    Rieckmann, P.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Dangond, F.
    Hicking, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 317 - 318
  • [44] AN ANALYSIS OF MALIGNANCY RISK IN THE CLINICAL DEVELOPMENT PROGRAMME OF CLADRIBINE TABLETS IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Galazka, Andrew
    Nolting, Axel
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Hicking, Christine
    King, John
    Dangond, Fernando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E17 - E17
  • [45] Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
    Stuve, Olaf
    Soerensen, Per Soelberg
    Leist, Thomas
    Giovannoni, Gavin
    Hyvert, Yann
    Damian, Doris
    Dangond, Fernando
    Boschert, Ursula
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
  • [46] Clinical development plan for cladribine tablets, an oral immunomodulator, for the treatment of multiple sclerosis
    Viglietta, V.
    Greenberg, S.
    Mikol, D.
    Weiner, J.
    Alteri, E.
    Chang, P.
    Krumwieh, D.
    Musch, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S126 - S126
  • [47] European experience of cladribine tablets in elderly multiple sclerosis: Could it be the last treatment ?
    de Seze, Jerome
    Zecca, Chiara
    Castelnovo, Giovanni
    Ayrignac, Xavier
    Patrick, Vermersch
    Gobbi, Claudio
    Claudia, Mallucci
    Dalliere, Clarisse Carra
    Pierre, Labauge
    Bigaut, Kevin
    Laurent, Kremer
    Collongues, Nicolas
    Lanotte, Livia
    Thouvenot, Eric
    Ernon, Christine
    Dive, Dominique
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 344 - 345
  • [48] Late stage clinical development plan for cladribine tablets in the treatment of multiple sclerosis
    Viglietta, V.
    Greenberg, S.
    Mikol, D.
    Weiner, J.
    Alteri, E.
    Chang, P.
    Krumwieh, D.
    Musch, B.
    JOURNAL OF NEUROLOGY, 2010, 257 : S143 - S144
  • [49] Danish experience with cladribine tablets in the treatment of relapsing multiple sclerosis: a nationwide study
    Sorensen, P. S.
    Heick, A.
    Petersen, T.
    Joensen, H.
    Kopp, T. I.
    Sellebjerg, F.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 165 - 165
  • [50] Recommendations for the use of cladribine tablets in recurring multiple sclerosis
    Oreja-Guevara, Celia
    Garcia-Merino, Juan A.
    Saiz, Albert
    Rodriguez-Antiguedad, Alfredo
    Alvarez-Cermeno, Jose C.
    Estrada-Perez, Vicente
    Izquierdo, Guillermo
    Fernandez, Oscar
    REVISTA DE NEUROLOGIA, 2019, 69 : S1 - S9